Polymyxin Impurity 1 is a lipopeptide-related species arising from altered acylation or peptide-cyclization pathways. Its structural differences affect hydrophobicity and ion-binding properties. Researchers analyze it for comprehensive impurity fingerprinting. Applications include QC refinement, lipopeptide degradation studies, and structural variant comparison.
CAT No: R2836
CAS No:343979-23-7
Synonyms/Alias:N-((S)-4-amino-1-(((2S,3R)-1-(((S)-4-amino-1-oxo-1-(((3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-((R)-1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosan-21-yl)amino)butan-2-yl)amino)-3-hydroxy-1-oxobutan-2-yl)amino)-1-oxobutan-2-yl)-3-hydroxy-6-methyloctanamide
Polymyxin Impurity 1 is a structurally related analogue of the polymyxin class of cyclic lipopeptide antibiotics, widely recognized for their role in targeting Gram-negative bacterial membranes. As a defined impurity, it represents a minor molecular variant that can naturally arise during the biosynthesis or chemical production of polymyxin compounds. The presence and characterization of such impurities are of significant interest in pharmaceutical research, quality control, and analytical development, as they offer insights into the complexity of peptide antibiotic preparations and their potential impact on downstream applications.
Analytical method development: Polymyxin Impurity 1 serves as a crucial reference standard in the development and validation of analytical methods for the detection, quantification, and characterization of polymyxin-related substances. Its well-defined structure aids researchers in establishing high-performance liquid chromatography (HPLC), mass spectrometry (MS), and other chromatographic techniques for impurity profiling in both bulk drug substances and finished formulations. By providing a benchmark for method sensitivity and selectivity, it helps ensure the accuracy and reliability of impurity analysis in pharmaceutical quality control laboratories.
Pharmaceutical quality assessment: The inclusion of Polymyxin Impurity 1 in impurity profiling studies supports comprehensive quality assessment of polymyxin-based products. Monitoring the levels of specific impurities is essential for understanding batch-to-batch variability, process optimization, and risk evaluation associated with manufacturing. Detailed knowledge of this impurity enables scientists to meet stringent regulatory guidelines for impurity limits, contributing to the overall safety and consistency of peptide antibiotic preparations.
Peptide degradation studies: Researchers utilize Polymyxin Impurity 1 to investigate the degradation pathways and stability profiles of polymyxin compounds under various stress conditions. By tracking the formation and transformation of such impurities during forced degradation studies, it becomes possible to elucidate the mechanisms of peptide hydrolysis, oxidation, or other chemical modifications. These insights are vital for designing robust formulations and storage protocols that minimize degradation and maintain product integrity over time.
Process development and optimization: The detection and quantification of Polymyxin Impurity 1 during process development offer valuable feedback for refining synthetic or fermentation-based production of polymyxin antibiotics. By identifying critical process parameters that influence impurity generation, scientists can optimize reaction conditions, purification steps, and downstream processing to enhance product purity and yield. This targeted approach supports the efficient scale-up and reproducibility of peptide manufacturing workflows.
Structural elucidation and reference material: As a structurally characterized impurity, Polymyxin Impurity 1 provides a valuable reference point for elucidating the structure-activity relationships within the polymyxin family. Its availability enables advanced spectroscopic and chromatographic studies, facilitating the identification of unknown impurities and supporting the development of comprehensive impurity libraries. These efforts contribute to a deeper understanding of the chemical diversity and functional implications of peptide antibiotics, informing both academic research and industrial quality assurance initiatives.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More